| |
Univariate1
|
Multivariate2
|
|---|
|
Variable
|
Beta (β)
|
P value
|
OR (95% CI)
|
Beta (β)
|
P value
|
OR (95% CI)
|
|---|
|
Time-to-remis
|
-0.091
|
0.000
|
0.913 (0.889-0.939)
|
-0.094
|
0.000
|
0.910 (0.878-0.944)
|
|
RF positive
|
0.447
|
0.058
|
1.563 (0.985-2.481)
| | | |
|
Male gender
|
-0.379
|
0.067
|
0.685 (0.457-1.026)
| | | |
|
Age
|
0.007
|
0.302
|
1.007 (0.993-1.022)
| | | |
|
Baseline DAS
|
-0.302
|
0.001
|
0.740 (0.620-0.882)
| | | |
|
Baseline HAQ
|
-0.567
|
0.011
|
0.567 (0.367-0.878)
| | | |
|
Dis duration
|
-0.003
|
0.745
|
0.997 (0.982-1.013)
| | | |
|
44 SJC
|
-0.012
|
0.384
|
0.988 (0.963-1.015)
| | | |
|
53 TJC
|
-0.070
|
0.000
|
0.932 (0.903-0.962)
| | | |
|
ESR
|
-0.004
|
0.349
|
0.996 (0.988-1.004)
| | | |
|
VAS GH
|
-0.009
|
0.075
|
0.991 (0.980-1.001)
| | | |
- 1 Results of the univariate logistic regression model for sustaining remission (DAS<1.6 for at least 6 months or more) during 3 years of follow-up and baseline variables, given with odds ratios (OR) and 95% confidence intervals (95%CI). 2 Results of the final multivariate logistic regression model for sustaining remission (DAS<1.6 for at least 6 months or more) during 3 years of follow-up and baseline variables, given with odds ratios (OR) and 95% confidence intervals (95% CI).
- Remis = remission; RF = rheumatoid factor; DAS = disease activity score based on 53 tender joint counts (TJC) and 44 swollen joint counts (SJC); HAQ = health assessment questionnaire; Dis = disease; ESR = erythrocyte sedimentation rate; VAS = visual analogue scale; GH = general health. Time-to-remission was measured in months, age was measured in years and disease duration was measured in weeks.
